NSE: CARERATING | BSE: 534804

Mid-range Performer

Download real time

1628.50 26.80 (1.67%)

67.81% Gain from 52W Low

17,555 NSE+BSE Volume

NSE 10 Sep, 2025 1:58 PM (IST)

4,884

Market Cap

High in industry

0.6

Beta 1Year

Very Low volatility

CARE Ratings Ltd. share price target and research reports

Latest analyst research reports with target prices and PDF download for CARERATING, BSE:534804 CARE Ratings Ltd.

CARE Ratings Ltd.

08 Aug 2016

1628.50

1.67%

Credit Analysis & Research Ltd.

Buy: CARE Ratings Ltd.

ICICI Securities Limited

Reported rating revenues were at | 56.7 crore (up 18% YoY) vs. our estimates of | 54 crore. Higher growth was due to increase in both volumes & surveillance exercises carried out. Total volume of new debt rated increased from | 265000 crore to | 378000 crore with increases being witnessed in both corporate debt & bank loans rating • Other income was at | 2.5 crore vs. estimate of | 3.1 crore down 14.8% YoY mainly due to investments made for a longer tenure where income is booked only when earned & not on an accrual basis • EBITDA came in at | 35.3 crore vs. | 27.9 crore expected while the EBIDTA margin was at 62% vs. 52% expected. This was mainly due to higher revenue & lower-than-expected expenses of | 21.9 crore. Esop charges of | 1.34 crore in Q1FY16 were not there in Q1FY17. Further, other expenses saw a decline of 25% YoY to | 4.2 crore. They stay structurally positive on the rating business in next three to five years. ICICI Securities Limited maintain TP of | 1400 valuing at 23x FY18E EPS, maintain BUY.

Trendlyne has 4 reports on CARERATING updated in the last year from 2 brokers with an average target of Rs 1496.

CARE Ratings Ltd.'s price crossed above 30Day SMA today

CARE Ratings Ltd.

30 May 2016

1628.50

1.67%

Credit Analysis & Research Ltd.

Buy: CARE Ratings Ltd.

ICICI Securities Limited

ICICI Securities Ltd | Retail Equity Research Reported rating revenues were at | 75.2 crore in line with our estimates. On a YoY basis, revenues fell 3% YoY while QoQ it was...

CARE Ratings Ltd.'s price crossed above 30Day SMA today

CARE Ratings Ltd.

01 Feb 2016

1628.50

1.67%

Credit Analysis & Research Ltd.

Buy: CARE Ratings Ltd.

ICICI Securities Limited

Number of FII/FPI investors increased from 113 to 130 in Jun 2025 qtr.

CARE Ratings Ltd.

07 Dec 2015

1628.50

1.67%

Credit Analysis And Research Ltd (CARE): Proxy Play on Economic Recovery (Dec 07, 2015)

Buy: CARE Ratings Ltd.

Karvy

The company has posted a revenue growth of 10.6% for FY15. The revenue forCARE is derived mostly from the core ratings business. The revenue is expected to improve going forward by 12% for FY16E, 14% for FY17E and 16% for FY18E. Improvement in credit off-take is likely to boost the rating business across all the sectors in the years to come.

CARE Ratings Ltd. has gained 66.67% in the last 1 Year

Is CARE Ratings Ltd. worth buying?

175 Votes:

Buy 72.0%

Sell 18.29%

Hold 9.71%

RESEARCH REPORTS

Buy SEE REPORTS >

pdf

Not Rated SEE REPORTS >

pdf